Regorafenib - CanMED: HCPCS

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Medication Information

CanMED: HCPCS

Generic Name:

Regorafenib

Brand Name:

Stivarga

Strength:

40 mg

HCPCS:

NA

SEER*Rx Category:

Chemotherapy

Major Drug Class:

Tyrosine Kinase Inhibitor

Minor Drug Class:

VEGFR, FGF, PDGFR,KIT,RET,TIE2,DDR2,TrkQ,RAF,BRAF,SAPK2, PTK, Abl

Oral (Y/N):

Yes

FDA Approval Year:

2012

FDA Discontinuation Year:

CMS Effective Date:

CMS Discontinuation Date:

Status:

In Use